American Gene Technologies (“AGT”), a Rockville, Maryland-based clinical-stage biotechnology company, will participate at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9–10, 2026, in New York City. President Dr. Drew Palin is scheduled to deliver an investor presentation and meet one-on-one with investors. Dr. Palin’s presentation is slated for 11:30 a.m. ET on Sept. 10 at The Westin New York Grand Central. According to the announcement, the company is developing AGT103-T, a novel, one-time, gene-modified T-cell therapy that has demonstrated elimination of intact HIV reservoirs in humans.
To view the full press release, visit https://ibn.fm/EZM1l
About American Gene Technologies
American Gene Technologies (“AGT”) is a clinical-stage biotechnology company developing AGT103-T, a single-infusion gene-modified T-cell therapy and the only program to demonstrate elimination of intact HIV reservoirs in humans — sustained more than 865 days with peer-reviewed published data. With FDA Fast Track designation, 60+ patents, and $85 million raised, AGT is advancing a Phase 2 trial poised to disrupt the $40 billion annual HIV market by replacing a lifetime of medication with a one-time functional cure. The company is raising $55 million to fund the data readout.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]
InvestorWire is powered by IBN